Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different <i>KIT</i> MutationsYemarshet K. Gebreyohannes(KU Leuven), Agnieszka Woźniak(KU Leuven)Molecular Cancer TherapeuticsOctober 24, 201610.1158/1535-7163.mct-16-0224Cited by 32SaveCiteExport RISWatch citationsRelated PapersRobust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors|Clinical Cancer Research|2018|77